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Peripheral nerve injury causes neuropathic pain
accompanied by remarkable microgliosis in the spi-
nal cord dorsal horn. However, it is still debated
whether infiltrated monocytes contribute to injury-
induced expansion of the microglial population.
Here, we found that spinal microgliosis predomi-
nantly results from local proliferation of resident
microglia but not from infiltrating monocytes after
spinal nerve transection (SNT) by using two ge-
netic mouse models (CCR2RFP/+:CX3CR1GFP/+ and
CX3CR1creER/+:R26tdTomato/+ mice) as well as specific
staining of microglia and macrophages. Pharmaco-
logical inhibition of SNT-induced microglial prolifera-
tion correlated with attenuated neuropathic pain hy-
persensitivities. Microglial proliferation is partially
controlled by purinergic and fractalkine signaling,
as CX3CR1/ and P2Y12/ mice show reduced
spinal microglial proliferation and neuropathic pain.
These results suggest that local microglial prolifera-
tion is the sole source of spinal microgliosis, which
represents a potential therapeutic target for neuro-
pathic pain management.
INTRODUCTION
Microglia are the principal immune cells in the CNS and play crit-
ical roles in the surveillance, support, protection, and restoration
of tissue integrity (Kettenmann et al., 2011; Ransohoff and Perry,
2009). Neuropathic pain resulting from peripheral nerve injury is
associated with dramatic microgliosis in the spinal dorsal horn
(Calvo and Bennett, 2012; Zhuo et al., 2011). However, the pre-
cise origin of this injury-induced expansion of the microglial pop-
ulation is still debated. Particularly, it is controversial whether
blood-derivedmyeloid progenitors can contribute to the residentThis is an open access article under the CC BY-Nmicroglial pool under neuropathic pain conditions. For instance,
several studies using bone marrow chimeras with lethally irradi-
ated recipients favor the view that bone-marrow monocytes are
able to cross the blood-brain barrier (BBB) and differentiate into
parenchymal microglia (Djukic et al., 2006; Priller et al., 2001),
which is also reported after peripheral nerve injury (Echeverry
et al., 2011; Sawada et al., 2014; Zhang et al., 2007). In contrast,
recent studies found that circulating cells do not infiltrate into the
parenchyma without irradiation and transplantation (Ajami et al.,
2007; Li et al., 2013), raising the possibility that circulating cells
may not cross the intact BBB under pathological conditions.
Given the critical role ofmicrogliosis in neuropathic pain (Salter
andBeggs, 2014; Tsuda et al., 2005), we re-evaluated the infiltra-
tion of bone-marrow-derived monocytes in the spinal cord after
spinal nerve transection (SNT). We addressed the question
using two transgenic mouse lines: (1) double-transgenic
CCR2RFP/+:CX3CR1GFP/+ mice in which resident CX3CR1-posi-
tive microglia are labeled with GFP while circulating CCR2-pos-
itivemonocytes are labeledwith RFP (Saederup et al., 2010), and
(2) CX3CR1creER: R26 tdTomato reporter mice, which enabled us to
exclusively label resident microglia with tdTomato in the CNS
(Parkhurst et al., 2013). Surprisingly, we found that SNT-induced
spinal microgliosis results predominantly from local proliferation
ofmicroglia and not from infiltratedmonocytes. Pharmacological
or genetic inhibition of SNT-induced microglial proliferation
attenuated neuropathic pain hypersensitivities. These results
provide important insights into the cellular source of microgliosis
after peripheral nerve injury andmay inform potential therapeutic
strategies for the treatment of neuropathic pain.
RESULTS
No CCR2RFP Monocyte Infiltration in Spinal Dorsal Horn
after SNT in CCR2RFP/+:CX3CR1GFP/+ Mice
To test whether microgliosis is partially due to the infiltration of
blood-derived monocytes, we first took advantage of double-
transgenic CCR2RFP/+:CX3CR1GFP/+ mice bearing GFP-labeled
resident microglia and RFP-labeled monocytes (SaederupCell Reports 16, 605–614, July 19, 2016 ª 2016 The Author(s). 605
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. No Monocyte Infiltration into the Dorsal Horn of Spinal Cord after Spinal Nerve Transection
(A–C) Representative confocal images of the ipsilateral spinal cord at post-operative day (POD) 14 following spinal nerve transection (SNT) in double-transgenic
CCR2RFP/+:CX3CR1GFP/+ mice (A). Resident GFP+ microglia (CX3CR1GFP/+) are shown in green, and infiltrated RFP+ monocytes (CCR2RFP/+) are shown in red.
Dotted boxes show regions of higher magnification in the dorsal horn (DH; B) and ventral horn (VH; C), respectively. Note the obvious appearance of CCR2RFP/+
(legend continued on next page)
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et al., 2010). In sham control mice, there were noCCR2RFP/+ cells
in the spinal cord (Figure S1A), although a few patrolling
CCR2RFP/+ cells were detected in the dorsal root ganglia (DRG)
(Figure S1D). Since previous studies found blood-derived mono-
cytes in the spinal dorsal horn after partial sciatic nerve injury
(Sawada et al., 2014; Zhang et al., 2007), we expected that
CCR2RFP/+ monocytes would infiltrate into the dorsal horn
following SNT. Surprisingly, we never observed infiltrated
CCR2RFP/+ cells in the spinal dorsal horn at 3 days after SNT
(post-operative day 3 [POD 3]; data not shown) or at POD 7 or
POD 14, when neuropathic pain was well established (Figures
1A, 1B, S1B, and S1C). In contrast, we detected CCR2RFP/+
monocytes in the ipsilateral ventral horn of the spinal cord at
POD 7 and POD 14 after SNT (Figures 1A, 1C, and S1G–S1I),
probably due to direct injuries of ventral horn motor neurons.
CCR2RFP/+ monocytes were also found in the ipsilateral DRG
as well as in the damaged nerve stump (Figures 1D, 1E, S1D,
and S1E). Taking an alternative complementary approach to
investigate CCR2 monocyte infiltration in the spinal cord, we
monitored CCR2 mRNA by qRT-PCR in sham mice and at
POD 7 following SNT. We found that mRNA transcript for
CCR2 increased significantly to 5.57 ± 1.03-fold (p = 0.02) in
the ipsilateral ventral horn at POD 7 (n = 5) from 1.19 ± 0.32-
fold in shammice (n = 4) or 1.58 ± 0.61-fold in the ipsilateral dor-
sal horn (n = 5) (Figure S1J). Therefore, these results confirm that
CCR2-expressing cells are increased in the ipsilateral ventral,
but not dorsal, horn at POD 7 after SNT. Finally, to determine
whether CCR2RFP/+ monocytes have the ability to enter the spi-
nal dorsal horn, we used a well-established mouse contusion
model of spinal cord injury (SCI) (Wang et al., 2015) in
CCR2RFP/+:CX3CR1GFP/+ mice. Indeed, we found numerous
CCR2RFP/+ monocytes in spinal dorsal horn 7 days after SCI
(Figure S2A). Together, we demonstrate that blood-derived
CCR2RFP/+ monocytes did not infiltrate into the spinal dorsal
horn after peripheral nerve injury.
No CX3CR1+ Monocyte Infiltration after SNT in
CX3CR1creER/+: R26tdTomato/+ Reporter Mice
Although CCR2RFP/+ monocytes did not appear in the dorsal
horn after SNT, we cannot exclude the possibility that
CX3CR1+ monocytes are able to infiltrate in response to periph-
eral nerve injury. To circumvent the issue, we used the recently
established CX3CR1creER/+: R26tdTomato/+ line of reporter mice
in which resident microglia can be exclusively labeled with
tdTomato in the CNS (Parkhurst et al., 2013). This is because
resident microglia show a much slower turnover while blood-
derived CX3CR1+ cells are quickly replenished (Parkhurst
et al., 2013). We applied tamoxifen (intraperitoneally [i.p.]cells in the ipsilateral VH (C), but not DH (B). Scale bars represent 200 mm (A) and 5
before SNT and at POD7 after SNT are shown in Figures S1A–S1C and S1F–S1H
(D and E) CCR2RFP cell infiltration was found in L4 dorsal root ganglia (DRG
CCR2RFP/+:CX3CR1GFP/+ mice. Scale bar, 100 mm. Representative images of CCR
Figures S1D and S1E.
(F and G) Representative images of the spinal cord DH at POD 14 following SN
the region that is magnified in (G). Resident microglia are tdTomato+Iba1+ ce
tdTomatoIba1+ cells in the DH. Scale bar represents 150 mm (F) and 50 mm (G),
PODs 3 and 7 following SNT using CX3CR1creER/+: R26tdTomato/+ reporter mice a150 mg/kg in corn oil, four doses with 2-day intervals) to
CX3CR1creER/+: R26tdTomato/+mice and allowed a 4-week interval
for peripheral turnover before SNT surgery (Figure S3A). As
expected, while CD11b+ CX3CR1+ monocytes were largely
tdTomato negative (Figures S3B and S3C), CNS resident micro-
glia expressed tdTomato in sham control CX3CR1creER/+:
R26tdTomato/+ mice (Figure S3D). If there was monocyte infiltra-
tion after SNT, we should have been able to detect a population
of Iba1+ tdTomato– cells. However, we found no Iba1+
tdTomato monocytes in the dorsal horn at PODs 3, 7, and 14
after SNT (Figures 1F, 1G, and S3E–S3G), although these cells
were present in the ipsilateral DRG as well as in the damaged
nerve stump and ipsilateral ventral horn (data not shown). In
addition, Iba1+ tdTomato monocytes were found in the spinal
cord at 7 days after SCI (Figure S2B). These results indicate
that there is no infiltration of hematogenous CX3CR1+ mono-
cytes in the spinal dorsal horn after SNT.
No Monocyte Infiltration after SNT Revealed by P2Y12
and CD169 Immunostaining
To circumvent genetic manipulations, we first used wild-type
(WT) mice with immunostaining of P2Y12, a purinergic receptor
specific for resident microglia, but not for monocytes or macro-
phages (Butovsky et al., 2014), together with immunostaining of
Iba1, which labels both resident microglia and infiltrated mono-
cytes. In sham control WTmice, we found all Iba1+ cells had pos-
itive P2Y12 staining in the spinal cord (Figure 2A). We expected
to observe Iba1+/P2Y12 cells in the dorsal horn if monocyte
infiltration occurred after SNT. However, we found no Iba1+/
P2Y12 cells in the ipsilateral spinal dorsal horn at POD 7 (Fig-
ure 2A) and POD 14 (data not shown) after SNT. In addition to
P2Y12 and Iba1 immunostaining in WT mice, we also performed
P2Y12 staining in CX3CR1GFP/+ mice. Consistently, we did not
find GFP+/P2Y12 cells in spinal dorsal horn at POD 7 days after
SNT (Figure 2B). We also did not observe any P2Y12+ cells in the
damaged nerve stump at POD 7 after SNT in CX3CR1GFP/+ mice
consistent with microglial specific expression of P2Y12 (Fig-
ure 2C). Next, we studied monocyte infiltration after SNT by per-
forming immunohistochemistry for CD169, a well-known marker
for macrophages (Gao et al., 2015) in WT mice. We found that
while the sham control spinal cord lacked CD169+ cells, the ipsi-
lateral ventral horn exhibited CD169+ cells whereas the ipsilateral
dorsal horn showed no such infiltration at POD 7 after SNT (Fig-
ure 2D). As a positive control, we confirmed the presence of
CD169+ macrophages in the L4 DRG at POD 7 after SNT (Fig-
ure 2E). Taken together, by using mice with CCR2RFP-labeled
monocytes, resident microglial tdTomato reporter, microglia-
specific cell marker (P2Y12), and macrophage-specific marker0 mm (B and C). Representative images of CCR2RFP cell infiltration in DH and VH
.
; D) and the damaged spinal nerve stump (E) at POD 14 following SNT in
2RFP cell infiltration into DRG before SNT and at POD7 after SNT are shown in
T in CX3CR1creER/+: R26tdTomato/+ reporter mice (F). The dotted box indicates
lls and hematogenous monocytes are tdTomatoIba1+ cells. There are no
respectively (n = 4 mice per group). Representative images before SNT and at
re shown in Figure S3.
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Figure 2. No Monocyte Infiltration in the Spinal Dorsal Horn by P2Y12 and CD169 Immunostaining
(A) Representative confocal images of double immunostaining showing co-localization of P2Y12 (red) and Iba1 (white) signals in the spinal cord dorsal horn in
sham and POD 7 following SNT in WT mice (n = 4 per group). Scale bar, 50 mm.
(B) Representative confocal images of P2Y12 staining in the spinal dorsal horn showing CX3CR1GFP-positive (green) microglia are also P2Y12+ (red) in sham and
POD 7 after SNT in CX3CR1GFP/+ mice (n = 4 per group). Scale bar, 50 mm.
(C) No P2Y12+ cells were found in the damaged nerve stump in CX3CR1GFP/+ mice, and no P2Y12 immunostaining was found in the spinal dorsal horn of
P2Y12/ mice at POD 7 after SNT (n = 4 per group). Scale bar, 50 mm.
(D) Representative confocal images of double immunostaining showing co-localization of CD169 (green) and Iba1 (red) signals in the ipsilateral spinal cord at POD
7 in WT mice (n = 2–3 mice per group). Scale bar, 100 mm. Note the obvious appearance of CD169+ cells (green) in the ipsilateral VH, but not DH.
(E) CD169+ cell infiltration was also found in L4 dorsal root ganglia (DRG) at POD 7 in WT mice (n = 2–3 mice per group). Scale bar, 50 mm.(CD169), we have demonstrated that there is no infiltration of pe-
ripheral hematogenous monocytes into the spinal cord dorsal
horn after peripheral nerve injury. These results collectively indi-608 Cell Reports 16, 605–614, July 19, 2016cate that spinal microgliosis after SNT is not due to themonocyte
infiltration, in contrast to previous studies (Echeverry et al., 2011;
Sawada et al., 2014; Zhang et al., 2007).
Figure 3. Local Microglial Proliferation Dominates Spinal Microgliosis after Spinal Nerve Transection
(A) Representative confocal images of spinal cord DH showing co-localization of BrdU (green) and Iba1 (red) at POD 7 following SNT. BrdU (i.p. 100 mg/kg) was
applied immediately after SNT at two pulses per day for 7 days (n = 4–6 mice per time point). Inset is a z-sectioned image at high magnification, showing that
BrdU+ signals are located in the nuclei of Iba1+ microglia. Scale bar represents 200 mm or 10 mm for lower- and higher-magnification images, respectively.
Representative images of the co-localization at POD3 after SNT are shown in Figure S4A.
(B) Quantitative summary showing that the number of BrdU+Iba1+ microglia in the ipsilateral DH (lamina I–IV) at PODs 3 and 7 was dramatically increased after
SNT (see also Figures S4A and S4B for comparison of BrdU+ cells between contralateral and ipsilateral DH). Data are presented as mean ± SEM. Shown is
summarized data for the number of Iba1+ and Iba1+BrdU+ cells per square millimeter in DH in sham control and at PODs 3 and 7 after surgery (n = 4–6 mice per
time point).
(C and D) Microglial proliferation accounted for a majority of proliferating events after SNT. Shown is the percentage of BrdU+Iba1+ cells among total Iba1+ cells,
i.e., mitotic microglial cells in total microglia (C), or the percentage of BrdU+Iba1+ cells in BrdU+ cells, i.e., microglia in total mitotic cells (D) at PODs 3 and 7 after
SNT (n = 4 mice at POD 3 and n = 6 mice at POD 7).Local Proliferation of Resident Microglia Dominates
Spinal Microgliosis after SNT
Next, we examined the contribution of microglial proliferation to
SNT-induced spinal microgliosis. To this end, we first measured
the incorporation of thymidine analog bromodeoxyuridine (BrdU;
i.p. 100mg/kg, two pulses per day for 3 or 7 days) in Iba1+micro-
glia in spinal dorsal horn after SNT. We found the number of
BrdU+Iba1+microglia (includes actively proliferating and recently
post-mitotic cells) in ipsilateral dorsal horn at POD 3 and 7 after
SNTwas dramatically increased compared to that on the contra-
lateral side or sham control mice (Figures 3A, 3B, and S4A–S4C).
The percentage of BrdU+Iba1+ cells (mitotic microglia) of the to-
tal Iba1+ microglial cell population consistently reached up to
90% after SNT (88.8% ± 1.1% at POD 3 and 89.4% ± 1.2%
at POD 7; Figure 3C). In addition, BrdU+Iba1+ cells dominated
the BrdU+ mitotic cell population (86.1% ± 2.8% at POD 3 and84.6% ± 1.4% at POD 7; Figure 3D), while there was a small per-
centage of BrdU+/NG2+ oligodendrocyte progenitor cells (Fig-
ures S4D and S4G) and BrdU+/GFAP+ astrocytes (Figures S4E
and S4G), but no BrdU+/NeuN+ neurons (Figure S4F). These re-
sults indicate that microglial proliferation accounted for most of
the proliferating events after SNT. Therefore, local microglial pro-
liferation provides a sustainable source for microgliosis after pe-
ripheral nerve injury.
The Dynamics of Microglial Proliferation after SNT
To study the dynamics of spinal microglia proliferation, we per-
formed immunostaining for Ki-67 (a nuclear protein expressed
in all phases of the cell cycle except the resting phase; Taupin,
2007) to gain a snapshot of dividing microglia at different time
points after SNT. We found amarked increase in Ki-67+Iba1+ mi-
croglia that started at POD 2, peaked at POD 3, and thenCell Reports 16, 605–614, July 19, 2016 609
Figure 4. Dynamics of Microglial Proliferation in the Spinal Dorsal Horn after Spinal Nerve Transection
(A) Representative images of Ki-67 immunostaining in L4 lumbar DH at PODs 3 and 5 after SNT (n = 6 mice). Scale bar, 150 mm. Co-localization of Ki-67 im-
munostaining with Iba1+ microglia is shown in Figure S5A.
(B) The time course of Ki-67-expressing cells, which peaks at POD 3, in the DH after SNT. Data are presented asmean ± SEM. Values represent the number of Ki-
67+Iba1+ cells (per DH slice) (n = 6 mice per time point; ***p < 0.001 versus number of Ki67+Iba1 cells at the corresponding time point).
(C) Time-lapse images (180min) of a dividing GFP+microglia in acute spinal cord slices at POD 3 following SNT. Arrows denote the dividingmicroglia [parent cells
(white arrows); daughter cells (red arrows)] and time is presented as hr:min (n = 4mice). The dotted box shows the region with magnification. Scale bar represents
100 mm or 10 mm for lower- and higher-magnification images, respectively. Two-photon live imaging of microglia proliferation in the DH from spinal slice at POD3
after SNT is presented in Movie S1.returned to pre-injury levels later at POD 5–7 after SNT (Figures
4A and 4B). Specifically, the majority of Iba1+ microglial cells
are proliferating microglia (Ki-67+Iba1+ cells) at POD 3 after
SNT (89.9% ± 1.4%, Figures S5A and S5B). To directly monitor
local proliferation, we performed time-lapse two-photon imaging
of microglia in acute spinal cord slices from CX3CR1GFP/+ mice.
Indeed, we found that 10.6% of microglial cells divided within a
3-hr imaging time window at POD 3 after SNT (15 of 141 micro-
glia from four mice; Figure 4C; Movie S1). Together, these results
provide direct evidence that resident microglia in the dorsal horn
undergo active cell division after peripheral nerve injury.
Pharmacological Inhibition of Microgliosis Attenuated
Neuropathic Pain Hypersensitivities
If microglial proliferation is the major driver for microgliosis,
which is associated with neuropathic pain hypersensitivity, we
hypothesized that inhibition of microglial proliferation would
attenuate pain after peripheral nerve injury. To test this hypothe-
sis, we intrathecally administrated the anti-mitotic drug cytosine610 Cell Reports 16, 605–614, July 19, 2016arabinoside (AraC; 50 mg in 5 ml ACSF, twice per day at PODs 1–4
and then once per day at PODs 5–7) immediately after SNT. We
found that the number of Iba1+ microglia in the spinal dorsal horn
at POD 7 after SNTwas significantly reduced (by 39.7%) in AraC-
treatedmice comparedwith vehicle-treatedmice (p < 0.001; Fig-
ures 5A and 5B). Consistently, AraC treatment almost abolished
all increased BrdU+Iba1+ cells at POD 7 after SNT in ipsilateral
dorsal horn (Figures S5C and S5F). Also, there were very few
GFAP+ cells or NG2+ cells that were co-localized with BrdU la-
beling (Figures S5D–S5F). We found that AraC treatment did
not affect GFAP (137 ± 9.9 cells without and 134 ± 8.7 cells
with AraC per field of view; n = 5–7; p = 0.83) or NG2 (37.5 ±
2.1 cells without and 34.8 ± 3.6 cells with AraC per field of
view; n = 5–6; p = 0.58) cell numbers. Behaviorally, AraC treat-
ment dramatically reduced the SNT-induced thermal hyperalge-
sia (F (7, 192) = 14.8; day 3–4, p < 0.01; day 5–7, p < 0.001) and
mechanical allodynia (F (7, 192) = 45.3; day 2, p < 0.01; day 3–7,
p < 0.001; Figure 5C). In addition, we observed a positive corre-
lation between the number of dorsal horn microglia and the
Figure 5. Microglial Proliferation Determines Neuropathic Pain Hypersensitivities after Spinal Nerve Transection
The anti-mitotic drug cytosine arabinoside (AraC; i.t., 50 mg in 5 ml ACSF, twice per day at PODs 1–4 and then once per day at PODs 5–7) effectively decreases the
number of Iba1+ microglia after SNT.
(A) Representative confocal images of microglia (Iba1 staining) in the ipsilateral spinal cord at POD 7 following SNT in sham, SNT, and SNT+ AraC-treated mice
(n = 4 mice). Scale bar, 200 mm.
(B) Summarized data for the number of Iba1+ cells per square millimeter in the ipsilateral dorsal horn (lamina I–IV) from the three groups shown in (A) (n = 4 mice in
sham group; n = 7mice in the SNT and SNT + AraC groups). Data are presented asmean ± SEM; ***p < 0.001 compared with SNT control; ##p < 0.01, ###p < 0.001
compared with sham.
(C) Attenuation of mechanical allodynia and thermal hyperalgesia after SNT by intrathecally administered AraC. Data are presented as mean ± SEM (n = 7 mice
per group; **p < 0.01, ***p < 0.001 compared with SNT control).
(D) A positive correlation between the number of microglia in the DH and the extent of allodynia (index of AUC) after AraC administration (n = 4mice in sham group;
7 mice in both SNT and SNT + AraC groups). To further investigate the molecular mechanisms underlying microglial proliferation, we examined microglial
proliferation by BrdU labeling (BrdU; i.p. 100 mg/kg, one pulse per day at PODs 1–3) in CX3CR1/ mice and in P2Y12/ mice, both have reduced allodynia
compared with WT mice (Figures S6A and S6B).
(E) Representative confocal images showing double staining of BrdU+ (green) and Iba1+ (red) cells in the spinal cord DH at POD 7 following SNT in WT,
CX3CR1/, and P2Y12/ mice (n = 4 mice). Scale bar, 200 mm.
(F) Summarized data showing reduced number of BrdU+Iba1+ cells per square millimeter in DH in CX3CR1/ and P2Y12/mice compared with that in WTmice
at POD 7 following SNT. All data are mean ± SEM (n = 6–7mice; *p < 0.05 compared withWTmice). Further analysis of microglial proliferation in P2Y12/mice is
shown in Figures S6C–S6E.
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extent of allodynia after AraCadministration (R =0.92; Figure 5D).
Therefore, spinal microgliosis due to proliferation directly deter-
mines neuropathic pain hypersensitivities after peripheral nerve
injury.
Purinergic and Fractalkine Signaling in SNT-Induced
Microglial Proliferation
To further investigate the molecular regulators of microglial pro-
liferation after peripheral nerve injury, we turned to the microglia-
specific receptors CX3CR1 and P2Y12 (Butovsky et al., 2014;
Cardona et al., 2006). Consistent with previous reports (Gu
et al., 2016; Staniland et al., 2010; Tozaki-Saitoh et al., 2008),
neuropathic pain hypersensitivities were attenuated in both
CX3CR1/ (F (4, 100) = 44.6; day 2, p < 0.01; day 3, p <
0.001; day 5, p < 0.05; day 7, p < 0.05) and P2Y12/ (F (4,
100) = 30.7; day 3, p < 0.001; day 5, p < 0.001; day 7, p <
0.01) mice compared with WT mice after SNT (Figures S6A
and S6B). We then examined SNT-induced microglial prolifera-
tion by BrdU labeling in CX3CR1/ and P2Y12/ mice. Inter-
estingly, we found a significant reduction in BrdU+Iba1+ prolifer-
ating microglia in the ipsilateral spinal dorsal horn in both
CX3CR1/ and P2Y12/ mice compared with WT mice at
POD7 after SNT (BrdU; i.p., once per day at POD1–3; p < 0.05;
Figures 5E and 5F). Detailed analysis showed a decrease in
BrdU+Iba1+ cells starting at POD3 in P2Y12/ mice compared
with those in WT mice after SNT (Figures S6C–S6E). These re-
sults suggest that both CX3CR1 and P2Y12 receptors partici-
pate in microglial proliferation and thereby contribute, at least
in part, to neuropathic pain hypersensitivities after peripheral
nerve injury.
DISCUSSION
In the present study, we investigated the cellular origin of spinal
microgliosis and its contribution to pain hypersensitivities after
peripheral nerve injury. Our results show that SNT-induced spi-
nal microgliosis results predominantly from local self-renewal of
microglia, but not from infiltrating monocytes. Pharmacological
or genetic inhibition of SNT-induced microglial proliferation
attenuated neuropathic pain hypersensitivities. The current
study provides important insights on the pathogenesis of
neuropathic pain in several folds: (1) we unexpectedly found
that monocytes do not infiltrate the spinal cord dorsal horn after
peripheral nerve injury, in contrast to previous studies (Eche-
verry et al., 2011; Sawada et al., 2014; Zhang et al., 2007); (2)
we pinpointed that self-renewal of resident microglia is the
cellular basis for SNT-induced spinal microgliosis; (3) we char-
acterized the dynamics of microglial proliferation and directly
provided visual evidence of dividing spinal microglia after pe-
ripheral nerve injury; and (4) we found that microglial prolifera-
tion contributes to the SNT-induced neuropathic pain and is
controlled partially by microglial-specific receptors CX3CR1
and P2Y12.
Spinal microgliosis is a characteristic of microglial activation
following peripheral nerve injury (Calvo and Bennett, 2012;
Tsuda et al., 2005; Zhuo et al., 2011). It was long believed
that after peripheral nerve injury, bone-marrow-derived mono-
cytes infiltrate the spinal cord dorsal horn and differentiate into612 Cell Reports 16, 605–614, July 19, 2016parenchymal microglia (Echeverry et al., 2011; Sawada et al.,
2014; Zhang et al., 2007). Here, based on several lines of
evidence through multiple approaches using transgenic
CCR2RFP/+:CX3CR1GFP/+ mice, CX3CR1creER: R26RFP reporter
mice, and P2Y12 andCD169 immunostaining, we found, surpris-
ingly, that there are nomonocytes entering the spinal dorsal horn
within 14 days of SNT injury. Using bone marrow chimeras with
lethal irradiation, previous studies have observed that more than
40% of microglial cells in the spinal dorsal horn after peripheral
nerve injury are derived from bone marrow monocytes (Eche-
verry et al., 2011; Sawada et al., 2014; Zhang et al., 2007). The
discrepancy between these studies and ours is not entirely clear
but might be due to the different approaches that were used. It
has been proposed that irradiation or bone marrow transplanta-
tion may change the overall immune environment and/or impair
the blood-brain/spinal barrier, which represents an experimental
artifact that cannot be generalized (Ransohoff and Perry, 2009).
In favor of this idea, recent studies showed strong hematopoietic
cell engrafts in the mice brain in bone marrow chimeras with le-
thal irradiation, while no infiltration of hematopoietic cells was
observed in the bone marrow chimeras with parabiosis (Ajami
et al., 2007). These studies raised the possibility that circulating
cells may not cross the intact blood-brain/spinal barrier without
irradiation and/or transplantation, which is consistent with our
current study. Interestingly, previous studies found that periph-
eral nerve injury increased the permeability of the blood/spinal
cord barrier (Beggs et al., 2010; Echeverry et al., 2011), although
we did not observe Evans blue staining in spinal cord at POD 7
after SNT (data not shown). Nevertheless, our study suggests
that monocytes are not able to infiltrate the spinal dorsal horn
even if there is increased permeability of the blood/spinal cord
barrier after SNT.
Our study further showed that SNT-induced microgliosis is
driven primarily through local proliferation of resident microglia
in the spinal dorsal horn. The correlation of nerve injury and mi-
crogliosis makes it plausible to assume that primary afferent
derived injury signals might be the major trigger for microglial
proliferation. Indeed, recent studies suggest neuregulin-1 or
colony-stimulating factor 1 (CSF1) are critical for microglial pro-
liferation after peripheral nerve injury (Calvo et al., 2010; Guan
et al., 2016). Here, we found that two microglia-specific recep-
tors, CX3CR1 and P2Y12, participate in the nerve-injury-
inducedmicroglial proliferation in the spinal dorsal horn. Our re-
sults may explain at least in part the decreased neuropathic
pain hypersensitivities in the current study and those in previous
studies (Gu et al., 2016; Staniland et al., 2010; Tozaki-Saitoh
et al., 2008; Zhuang et al., 2007). Although the precise mecha-
nisms underlying CX3CR1 and P2Y12 in chronic pain are still
unclear, studies indeed suggest that both receptors are
coupled to p38 expression, which could lead to increased in-
flammatory responses (Kobayashi et al., 2008; Zhuang et al.,
2007). Future studies are needed to address how CX3CR1
and P2Y12 receptors directly or indirectly regulate microglial
proliferation in response to peripheral nerve injury. The current
study not only furthers our understanding of microglial mecha-
nisms underlying chronic pain but also provides potential ther-
apeutic strategies targeting microgliosis for the treatment of
neuropathic pain.
EXPERIMENTAL PROCEDURES
Animals
C57BL/6J (WT), CCR2RFP/+:CX3CR1GFP/+, CX3CR1creER: Rosa26tdTomato/+ re-
porter, CX3CR1GFP/+, CX3CR1GFP/GFP (CX3CR1/), and P2Y12/mice were
used in the present study. C57BL/6J mice were purchased from Charles
River Laboratories. All transgenic mice were purchased from The Jackson
Laboratory, except for the P2Y12/ mice (a gift from Dr. Michael Dailey,
University of Iowa) (Andre et al., 2003; Haynes et al., 2006) and CX3CR1creER
mice (a gift from Dr. Wen-Biao Gan, New York University) (Parkhurst et al.,
2013). CCR2RFP/+:CX3CR1GFP/+ mice were generated by crossbreeding
CCR2RFP/RFP mice (Saederup et al., 2010) with CX3CR1GFP/GFP mice (Jung
et al., 2000). CX3CR1creER:Rosa26tdTomato/+ reporter mice were generated by
crossbreeding CX3CR1CreER mice with Rosa26 tdTomato/+ mice. CX3CR1GFP/+
mice were generated by crossbreeding CX3CR1GFP/GFP mice with C57BL/6J
mice. All transgenic mice were on a C57BL/6J background, are viable, and
showed no detectable developmental defects. 6- to 12-week-old age-
matched male mice were used in accordance with institutional guidelines,
as approved by the animal care and use committee at Rutgers University
and Fourth Military Medical University. None of the mice underwent prior
experimentation before being used for this study. All animals were housed un-
der controlled temperature humidity and lighting (light: dark 12:12-hr cycle)
with food and water available ad libitum.
Inducible Expression of tdTomato in CNS Resident Microglia
To selectively label CNS resident microglia, CX3CR1creER:Rosa26 tdTomato/+ re-
porter mice were used. Tamoxifen (TM; Sigma) was dissolved in corn oil
(Sigma) and administered i.p. Adult CX3CR1creER: Rosa26 tdTomato/+ mice
received four doses of TM (150 mg/kg, 20 mg/ml in corn oil) in 48-hr intervals.
TM induced the expression of tdTomato in resident microglial and infiltrating
monocytes. Since monocytes have a shorter lifespan due to rapid turnover,
tdTomato-expressing monocytes are replaced by monocytes lacking
tdTomato at 4 weeks after TM inductions, while resident microglia still have
tdTomato (Parkhurst et al., 2013). Hence, to observe monocyte infiltration, spi-
nal nerve transection or spinal cord contusion injury was performed at 4 weeks
after TM inductions.
Spinal Nerve Transection Surgery
Mice were anesthetized with isoflurane in O2 (induction: 4%–5% isoflurane;
maintenance: 1.5%–2.5% isoflurane). Lumbar 4 SNT surgery was performed
as previously described (Chung et al., 2004; Gu et al., 2016). Briefly, a small
incision to the skin overlaying L4-S1 was made, followed by retraction of
the paravertebral musculature from the vertebral transverse processes. The
L4 spinal nerve was identified, lifted slightly, transected, and removed
1–1.5 mm from the end to DRG. The wound was irrigated with saline and
closed in with a two-layer suture by closing the muscles with 6-0 silk sutures
and the skin with 5-0 silk sutures. The L4 spinal nerve was exposed without
ligation or transection in sham-operated mice. POD was used to represent
the time point following SNT.
Drug Administration
The thymidine analog BrdU (Sigma) was used to label proliferating and recently
postmitotic cells in the spinal cord after SNT surgery. The BrdU solution was
diluted in 1 M PBS just before use and intraperitoneally administered (i.p.
100 mg/kg). To inhibit microglial proliferation, the anti-mitotic drug AraC
(50 mg in 5 ml ACSF) was intrathecally injected to mice at given time points after
SNT. For intrathecal (i.t.) drug administration, mice were hand restricted and
injected by direct lumbar puncture between L5 and L6 vertebrae of the spine,
using a 10-ml Hamilton syringe (Hamilton Bonaduz AG) with a 31G needle. Suc-
cessful insertion was indicated by a tail flick response.
Mouse Model of Spinal Cord Contusion Injury, Monocyte Flow
Cytometry, Pain Behavioral Tests, Immunohistochemistry, Spinal
Cord Slice Preparation and Two-Photon Imaging, qRT-PCR, and
Statistical Analysis
For further details regarding materials and methods used in this work, please
see the Supplemental Experimental Procedures.SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
six figures, and one movie and can be found with this article online at http://
dx.doi.org/10.1016/j.celrep.2016.06.018.
AUTHOR CONTRIBUTIONS
N.G. and J.P. designed and performed most of the experiments, analyzed the
data, and wrote the manuscript. M.M., X.W., and U.B.E. performed some
behavior experiments and wrote the manuscript. X.W., D.S., and Y.R. assisted
with spinal cord injury experiments. E.D.-B. and W.Y. provided some experi-
mental design and expert discussion of the project. H.D. and L.-J.W.
conceived the study, supervised the overall project, designed the experi-
ments, and wrote the manuscript.
ACKNOWLEDGMENTS
This work was supported by grants from the NIH (R01NS088627,
R21DE025689, and T32ES007148), the New Jersey Commission on Spinal
Cord Research (CSCR15ERG015 and CSCR13IRG006), and the National Nat-
ural Science Foundation of China (81200857, 81571351, and 81371510). We
thank Dr. Michael E. Dailey (University of Iowa) for providing us with P2Y12
knockout mice, Dr. Wen-Biao Gan (New York University) for providing us
with CX3CR1CreER/+ mice, and Noriko Goldsmith (Rutgers University) for tech-
nical assistance with confocal microscopy.
Received: January 15, 2016
Revised: May 2, 2016
Accepted: May 31, 2016
Published: June 30, 2016
REFERENCES
Ajami, B., Bennett, J.L., Krieger, C., Tetzlaff, W., and Rossi, F.M. (2007). Local
self-renewal can sustain CNS microglia maintenance and function throughout
adult life. Nat. Neurosci. 10, 1538–1543.
Andre, P., Delaney, S.M., LaRocca, T., Vincent, D., DeGuzman, F., Jurek, M.,
Koller, B., Phillips, D.R., and Conley, P.B. (2003). P2Y12 regulates platelet
adhesion/activation, thrombus growth, and thrombus stability in injured ar-
teries. J. Clin. Invest. 112, 398–406.
Beggs, S., Liu, X.J., Kwan, C., and Salter, M.W. (2010). Peripheral nerve injury
and TRPV1-expressing primary afferent C-fibers cause opening of the blood-
brain barrier. Mol. Pain 6, 74.
Butovsky, O., Jedrychowski, M.P., Moore, C.S., Cialic, R., Lanser, A.J., Ga-
briely, G., Koeglsperger, T., Dake, B., Wu, P.M., Doykan, C.E., et al. (2014).
Identification of a unique TGF-b-dependent molecular and functional signature
in microglia. Nat. Neurosci. 17, 131–143.
Calvo, M., and Bennett, D.L. (2012). The mechanisms of microgliosis and pain
following peripheral nerve injury. Exp. Neurol. 234, 271–282.
Calvo, M., Zhu, N., Tsantoulas, C., Ma, Z., Grist, J., Loeb, J.A., and Bennett,
D.L. (2010). Neuregulin-ErbB signaling promotes microglial proliferation and
chemotaxis contributing to microgliosis and pain after peripheral nerve injury.
J. Neurosci. 30, 5437–5450.
Cardona, A.E., Pioro, E.P., Sasse, M.E., Kostenko, V., Cardona, S.M., Dijkstra,
I.M., Huang, D., Kidd, G., Dombrowski, S., Dutta, R., et al. (2006). Control
of microglial neurotoxicity by the fractalkine receptor. Nat. Neurosci. 9,
917–924.
Chung, J.M., Kim, H.K., and Chung, K. (2004). Segmental spinal nerve ligation
model of neuropathic pain. Methods Mol. Med. 99, 35–45.
Djukic, M., Mildner, A., Schmidt, H., Czesnik, D., Br€uck, W., Priller, J., Nau, R.,
and Prinz, M. (2006). Circulating monocytes engraft in the brain, differentiate
into microglia and contribute to the pathology following meningitis in mice.
Brain 129, 2394–2403.Cell Reports 16, 605–614, July 19, 2016 613
Echeverry, S., Shi, X.Q., Rivest, S., and Zhang, J. (2011). Peripheral nerve
injury alters blood-spinal cord barrier functional and molecular integrity
through a selective inflammatory pathway. J. Neurosci. 31, 10819–10828.
Gao, L., Brenner, D., Llorens-Bobadilla, E., Saiz-Castro, G., Frank, T.,
Wieghofer, P., Hill, O., Thiemann, M., Karray, S., Prinz, M., et al. (2015). Infiltra-
tion of circulating myeloid cells through CD95L contributes to neurodegenera-
tion in mice. J. Exp. Med. 212, 469–480.
Gu, N., Eyo, U.B., Murugan, M., Peng, J., Matta, S., Dong, H., and Wu, L.J.
(2016). Microglial P2Y12 receptors regulate microglial activation and surveil-
lance during neuropathic pain. Brain Behav. Immun. 55, 82–92.
Guan, Z., Kuhn, J.A., Wang, X., Colquitt, B., Solorzano, C., Vaman, S., Guan,
A.K., Evans-Reinsch, Z., Braz, J., Devor, M., et al. (2016). Injured sensory
neuron-derived CSF1 induces microglial proliferation and DAP12-dependent
pain. Nat. Neurosci. 19, 94–101.
Haynes, S.E., Hollopeter, G., Yang, G., Kurpius, D., Dailey, M.E., Gan, W.B.,
and Julius, D. (2006). The P2Y12 receptor regulates microglial activation by
extracellular nucleotides. Nat. Neurosci. 9, 1512–1519.
Jung, S., Aliberti, J., Graemmel, P., Sunshine, M.J., Kreutzberg, G.W., Sher, A.,
and Littman, D.R. (2000). Analysis of fractalkine receptor CX(3)CR1 function by
targeted deletion and green fluorescent protein reporter gene insertion. Mol.
Cell. Biol. 20, 4106–4114.
Kettenmann, H., Hanisch, U.K., Noda, M., and Verkhratsky, A. (2011). Physi-
ology of microglia. Physiol. Rev. 91, 461–553.
Kobayashi, K., Yamanaka, H., Fukuoka, T., Dai, Y., Obata, K., and Noguchi, K.
(2008). P2Y12 receptor upregulation in activated microglia is a gateway of p38
signaling and neuropathic pain. J. Neurosci. 28, 2892–2902.
Li, T., Pang, S., Yu, Y., Wu, X., Guo, J., and Zhang, S. (2013). Proliferation of
parenchymal microglia is the main source of microgliosis after ischaemic
stroke. Brain 136, 3578–3588.
Parkhurst, C.N., Yang, G., Ninan, I., Savas, J.N., Yates, J.R., 3rd, Lafaille, J.J.,
Hempstead, B.L., Littman, D.R., and Gan, W.B. (2013). Microglia promote
learning-dependent synapse formation through brain-derived neurotrophic
factor. Cell 155, 1596–1609.
Priller, J., Fl€ugel, A., Wehner, T., Boentert, M., Haas, C.A., Prinz, M., Ferna´n-
dez-Klett, F., Prass, K., Bechmann, I., de Boer, B.A., et al. (2001). Targeting
gene-modified hematopoietic cells to the central nervous system: use of green
fluorescent protein uncovers microglial engraftment. Nat. Med. 7, 1356–1361.614 Cell Reports 16, 605–614, July 19, 2016Ransohoff, R.M., and Perry, V.H. (2009). Microglial physiology: unique stimuli,
specialized responses. Annu. Rev. Immunol. 27, 119–145.
Saederup, N., Cardona, A.E., Croft, K., Mizutani, M., Cotleur, A.C., Tsou, C.L.,
Ransohoff, R.M., and Charo, I.F. (2010). Selective chemokine receptor usage
by central nervous system myeloid cells in CCR2-red fluorescent protein
knock-in mice. PLoS ONE 5, e13693.
Salter, M.W., and Beggs, S. (2014). Sublime microglia: expanding roles for the
guardians of the CNS. Cell 158, 15–24.
Sawada, A., Niiyama, Y., Ataka, K., Nagaishi, K., Yamakage, M., and Fujimiya,
M. (2014). Suppression of bone marrow-derived microglia in the amygdala im-
proves anxiety-like behavior induced by chronic partial sciatic nerve ligation in
mice. Pain 155, 1762–1772.
Staniland, A.A., Clark, A.K., Wodarski, R., Sasso, O., Maione, F., D’Acquisto,
F., and Malcangio, M. (2010). Reduced inflammatory and neuropathic pain
and decreased spinal microglial response in fractalkine receptor (CX3CR1)
knockout mice. J. Neurochem. 114, 1143–1157.
Taupin, P. (2007). Protocols for studying adult neurogenesis: insights and
recent developments. Regen. Med. 2, 51–62.
Tozaki-Saitoh, H., Tsuda, M., Miyata, H., Ueda, K., Kohsaka, S., and Inoue, K.
(2008). P2Y12 receptors in spinal microglia are required for neuropathic pain
after peripheral nerve injury. J. Neurosci. 28, 4949–4956.
Tsuda, M., Inoue, K., and Salter, M.W. (2005). Neuropathic pain and spinal mi-
croglia: a big problem from molecules in ‘‘small’’ glia. Trends Neurosci. 28,
101–107.
Wang, X., Cao, K., Sun, X., Chen, Y., Duan, Z., Sun, L., Guo, L., Bai, P., Sun, D.,
Fan, J., et al. (2015). Macrophages in spinal cord injury: phenotypic and func-
tional change from exposure to myelin debris. Glia 63, 635–651.
Zhang, J., Shi, X.Q., Echeverry, S., Mogil, J.S., De Koninck, Y., and Rivest, S.
(2007). Expression of CCR2 in both resident and bone marrow-derived micro-
glia plays a critical role in neuropathic pain. J. Neurosci. 27, 12396–12406.
Zhuang, Z.Y., Kawasaki, Y., Tan, P.H., Wen, Y.R., Huang, J., and Ji, R.R.
(2007). Role of the CX3CR1/p38 MAPK pathway in spinal microglia for the
development of neuropathic pain following nerve injury-induced cleavage of
fractalkine. Brain Behav. Immun. 21, 642–651.
Zhuo, M., Wu, G., andWu, L.J. (2011). Neuronal and microglial mechanisms of
neuropathic pain. Mol. Brain 4, 31.
